Wang Meng, Han Dongsheng, Zhang Jiawei, Zhang Rui, Li Jinming
National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, PR China; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, PR China; Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, PR China.
National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, PR China; Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, PR China; Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, PR China.
Biosens Bioelectron. 2021 Jul 15;184:113212. doi: 10.1016/j.bios.2021.113212. Epub 2021 Apr 2.
Methods that enable specific and sensitive detection of DNA are greatly required for high-fidelity sequence measurement and single-nucleotide variations (SNVs) genotyping. The CRISPR (clustered regularly interspaced short palindromic repeats)/Cas systems have provided revolutionary tools for detecting nucleic acids. However, most of the current CRISPR/Cas-based DNA biosensing platforms suffer from inherent off-target effects of Cas proteins and require pre-amplification processes, which compromise the analytical fidelity. In this work, a CRISPR/Cas9-triggered hairpin probe-mediated biosensing method (namely CHP) was used to directly read the original DNA sequences, while effectively neutralizing the off-target effect and achieving high sensitivity. This technique can quantify DNA targets with a limit of detection (LOD) at the attomole level and identify SNVs with allelic fractions as low as 0.01%~0.1%. Moreover, we show that the CHP system is applicable in detecting mutations in serum samples without DNA isolation steps. Collectively, the CHP system is a sensitive and high-fidelity platform, which promises a great potential for providing robust tool for DNA sequence analysis and SNVs genotyping.
对于高保真序列测量和单核苷酸变异(SNV)基因分型而言,非常需要能够实现对DNA进行特异性和灵敏检测的方法。CRISPR(成簇规律间隔短回文重复序列)/Cas系统为核酸检测提供了革命性的工具。然而,当前大多数基于CRISPR/Cas的DNA生物传感平台都存在Cas蛋白固有的脱靶效应,并且需要预扩增过程,这会损害分析的保真度。在这项工作中,一种由CRISPR/Cas9触发的发夹探针介导的生物传感方法(即CHP)被用于直接读取原始DNA序列,同时有效消除脱靶效应并实现高灵敏度。该技术能够以阿托摩尔水平的检测限(LOD)对DNA靶标进行定量,并识别等位基因分数低至0.01%~0.1%的SNV。此外,我们表明CHP系统适用于在无需DNA分离步骤的情况下检测血清样本中的突变。总体而言,CHP系统是一个灵敏且高保真的平台,有望为DNA序列分析和SNV基因分型提供强大工具,具有巨大潜力。